From: Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II
Flow rate (mL/min)
FIK
CLN
Mean area ± SD
RSD
0.9
6,324,955 ± 5288.73
0.08
1,054,320 ± 1316.86
0.12
1.0
6,326,703 ± 4516.74
0.07
1,057,859 ± 1406.11
0.13
1.1
6,327,902 ± 5043.82
1,058,142 ± 1812.43
0.17